Description Molecular Details Molecular Formula: C165H271N47O46 Molecular Weight: ~ 3647.3 g/mol Peptide Type: Growth Hormone Releasing Hormone (GHRH) analog Modification: Attached to Drug Affinity Complex (DAC), which binds to serum albumin, dramatically extending half-life. Mechanism of Action (Research Use Only) CJC-1295 with DAC works by mimicking endogenous GHRH, stimulating the pituitary to release growth hormone (GH), which subsequently increases IGF-1 levels. Key points: DAC modification allows binding to serum proteins, extending half-life to about 5–8 days (vs. ~30 minutes for CJC-1295 without DAC). Provides sustained GH release rather than pulsatile bursts. Designed for less frequent dosing in research models. Research Applications Endocrine and metabolic studies involving GH/IGF-1 axis. Muscle and tissue regeneration models. Bone density and cartilage support in GH-related studies. Anti-aging and longevity research focused on anabolic pathways. Storage & Handling (Research Use Only) Form: Lyophilized peptide powder. Storage: Lyophilized: −20 °C long term. Reconstituted: 2–8 °C (stable ~7–10 days). Reconstitution: Sterile bacteriostatic water. Solubility: Fully water-soluble. Use: For laboratory research only. Not for human or veterinary use.
